Western blot
0.2-1 ug/mlELISA Titer: 1:1562500Positive Control: Human Lung| Product Name | Rabbit anti-CLN6 polyclonal antibody - middle region |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | FLJ20561, HsT18960, nclf, CLN4A |
| Immunogen | The immunogen for anti-CLN6 antibody: synthetic peptide directed towards the middle region of human CLN6 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | BovineDogHorseHumanMousePigRabbitRatSheepZebra Fish |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | CLN6 |
|---|---|
| Gene Synonyms | FLJ20561 HsT18960 nclf CLN4A |
| Gene Full Name | Ceroid-lipofuscinosis, neuronal 6, late infantile, variant |
| Gene Summary | CLN6 is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely CLN6 involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function. |
| Alternative Names | FLJ20561 HsT18960 nclf CLN4A |
| Molecular Weight(MW) | 36kDa |
| Sequence | 311 amino acids |
Western blot
0.2-1 ug/mlELISA Titer: 1:1562500Positive Control: Human Lung| Application Notes | WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
